Armata Pharmaceuticals (ARMP) Other Working Capital Changes (2013 - 2026)
Armata Pharmaceuticals' (ARMP) quarterly Other Working Capital Changes came in at -$948000.0 in Q1 2026, down 75.88% year-on-year from -$3.9 million in Q1 2025, and down 257.74% quarter-over-quarter from -$265000.0 in Q4 2025.
Armata Pharmaceuticals (ARMP) Other Working Capital Changes (2013 - 2026) Analysis & Trends
Armata Pharmaceuticals has disclosed Other Working Capital Changes across 14 years of filings, most recently posting -$948000.0 for Q1 2026.
- Other Working Capital Changes for Q1 2026 came in at -$948000.0, down 75.88% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.4 million (up 62.66% YoY), and the FY2025 annual result was -$1.0 million, up 79.87% from the prior year.
- Other Working Capital Changes came in at -$948000.0 for Q1 2026 at Armata Pharmaceuticals, down from -$265000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $6.2 million in Q4 2022 to a low of -$11.9 million in Q3 2023.
- The 5-year median for Other Working Capital Changes is -$539000.0 (2025), against an average of -$249764.7.
- Peak annual rise in Other Working Capital Changes reached 2268.32% in 2022, while the deepest fall reached 4720.0% in 2022.
- Armata Pharmaceuticals' Other Working Capital Changes stood at $6.2 million in 2022, then retreated by 21.08% to $4.9 million in 2023, then sank by 119.24% to -$942000.0 in 2024, then surged by 71.87% to -$265000.0 in 2025, then tumbled by 257.74% to -$948000.0 in 2026.
- The last three Other Working Capital Changes figures came in at -$948000.0 (Q1 2026), -$265000.0 (Q4 2025), and -$257000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | Armata Pharmaceuticals | 275.44 Mn | 270.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -948,000.00 |
| Mar 31, 2026 | -948,000.00 |
| Dec 31, 2025 | -265,000.00 |
| Dec 31, 2025 | -265,000.00 |
| Sep 30, 2025 | -257,000.00 |
| Sep 30, 2025 | -257,000.00 |
| Jun 30, 2025 | 33,000.00 |
| Jun 30, 2025 | 33,000.00 |
| Mar 31, 2025 | -539,000.00 |
| Mar 31, 2025 | -539,000.00 |
| Dec 31, 2024 | -942,000.00 |
| Dec 31, 2024 | -942,000.00 |
| Sep 30, 2024 | -938,000.00 |
| Sep 30, 2024 | -938,000.00 |
| Jun 30, 2024 | -1.43 Mn |
| Jun 30, 2024 | -1.43 Mn |
| Mar 31, 2024 | -1.80 Mn |
| Mar 31, 2024 | -1.80 Mn |
| Dec 31, 2023 | 4.90 Mn |
| Dec 31, 2023 | 4.90 Mn |